Navigation Links
Gene Therapy - Technologies, Markets and Companies
Date:11/30/2011

rders 335

8. Gene therapy of viral infections 338

Introduction 338

Acquired Immunodeficiency Syndrome (AIDS) 338

Current management of AIDS 338

Gene therapy strategies in HIV/AIDS 339

HIV/AIDS vaccines 339

Insertion of protective genes into target cells. 340

Cell/gene therapies for HIV/AIDS 341

Transplantation of genetically modified T-cells 341

Transplantation of genetically modified hematopoietic cells 341

Anti-HIV ribozyme delivered in hematopoietic progenitor cells 342

Inhibition of HIV-1 replication by lentiviral vectors 342

VRX496 342

Intracellular immunization 343

Engineered cellular proteins such as soluble CD4s 343

Intracellular antibodies 343

Anti-rev single chain antibody fragment 343

Use of genes to chemosensitize HIV-1 infected cells 344

Autocrine interferon (INF)-? production by somatic cell gene therapy 344

Antisense approaches to AIDS 344

RNA decoys 344

Antisense oligodeoxynucleotides 344

RNA decoys 345

Ribozymes 345

RNAi applications in HIV/AIDS 346

siRNA-directed inhibition of HIV-1 infection 346

Role of the nef gene during HIV-1 infection and RNAi 346

Bispecific siRNA constructs 347

Targeting CXCR4 with siRNAs 347

Targeting CCR5 with siRNAs 347

Companies involved in developing gene therapy for HIV/AIDS 348

Conclusions regarding gene therapy of HIV/AIDS 349

Genetic vaccines for other viral infections 349

Cytomegalic virus infections 349

Viral hepatitis 350

Vaccine for hepatitis B virus 350

Vaccine for hepatitis C virus 351

Vaccine for herpes simplex virus 351

DNA vaccine against rabies 351

DNA vaccine for Ebola 352

Vaccines for avian influenza 352

Future prospects of DNA vaccines for avian influenza 353

Human trial of a DNA vaccine for avian influenza 3
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Data From REMEDEE Trial Featuring OrbusNeichs Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
2. Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis
3. Progenitor Cell Therapy, a Wholly-Owned Subsidiary of NeoStem, Inc., Announces Additions to Management
4. NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
5. New Findings Reported by TJ Gan and Authors from Duke Anesthesiology Demonstrate Efficacy of Cheetah Medicals NICOM® Bioreactance® Technology to Guide Goal Directed Intraoperative Therapy
6. Antigen Express to Present at Second Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference at the New York Academy of Medicine
7. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
8. NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011
9. EGEN, Inc. Collaborates With Nanotechnology Characterization Laboratory on Brain Cancer Therapy
10. SanBio Announces Site Opening of Phase 1/2a Clinical Trial of Novel Cell Therapy in Stable Stroke Patients at University of Pittsburgh Medical Center
11. Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... (Nasdaq: MATK ) announced today that it will ... Pharmaceuticals Conference in,London. The conference is being held May ... Steve Dubin, CEO will be presenting on Wednesday,May 28, ... Interested parties may access a live audio webcast ...
... the news release, "Rosetta Genomics Reports First Quarter 2008,Financial ... Rosetta Genomics Ltd,nasdaq:ROSG over PR Newswire, we are advised ... the conference call, as stated beneath the header,Conference Call ... ET,as previously issued. Complete, corrected release follows:, , ...
... YORK, May 21 Citing increasing demand for a ... Dr. Lance H. Brown has expanded his Manhattan practice ... His telephone number,there is 631-725-1771., As summer draws ... of too many seasons in the sun. Those seeking ...
Cached Biology Technology:/C O R R E C T I O N -- Rosetta Genomics Ltd/ 2/C O R R E C T I O N -- Rosetta Genomics Ltd/ 3/C O R R E C T I O N -- Rosetta Genomics Ltd/ 4/C O R R E C T I O N -- Rosetta Genomics Ltd/ 5/C O R R E C T I O N -- Rosetta Genomics Ltd/ 6/C O R R E C T I O N -- Rosetta Genomics Ltd/ 7/C O R R E C T I O N -- Rosetta Genomics Ltd/ 8/C O R R E C T I O N -- Rosetta Genomics Ltd/ 9/C O R R E C T I O N -- Rosetta Genomics Ltd/ 10/C O R R E C T I O N -- Rosetta Genomics Ltd/ 11/C O R R E C T I O N -- Rosetta Genomics Ltd/ 12/C O R R E C T I O N -- Rosetta Genomics Ltd/ 13/C O R R E C T I O N -- Rosetta Genomics Ltd/ 14/C O R R E C T I O N -- Rosetta Genomics Ltd/ 15/C O R R E C T I O N -- Rosetta Genomics Ltd/ 16/C O R R E C T I O N -- Rosetta Genomics Ltd/ 17/C O R R E C T I O N -- Rosetta Genomics Ltd/ 18/C O R R E C T I O N -- Rosetta Genomics Ltd/ 19/C O R R E C T I O N -- Rosetta Genomics Ltd/ 20Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY 2
(Date:12/17/2014)... 16, 2014  Automation is fundamentally transforming the ... than at international borders. Over the past decade, ... allowed veteran travelers to self process through border ... Kiosks at an increasing number of airports, seaports, ... According to Maxine Most , Principal ...
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Graeme Ian Bell, PhD, the Louis Block Distinguished Service ... in the Kovler Diabetes Center at the University of ... for 2012 for his pioneering work in understanding the ... diabetes. The prize, the world,s largest award ...
... Mak Saito, a biogeochemist at Woods Hole Oceanographic Institution, has ... by the Gordon and Betty Moore Foundation. Saito is one ... funds from a total of up to $35 million over ... marine microbial ecology. "We are grateful to the Moore ...
... Wilmington, DE This month, Molecular Pharmaceutics ... for Childhood Cancer Research and the Materials Science ... about the potential for nanotechnology to deliver chemotherapeutic ... without harming healthy cells. To date, nanoparticle-based drug ...
Cached Biology News:University of Chicago's Graeme Bell receives international diabetes prize 2University of Chicago's Graeme Bell receives international diabetes prize 3WHOI scientist receives marine microbiology initiative investigator award from Moore Foundation 2Nanotechnology drug delivery shows promise for treatment of pediatric cancer 2
... (6-28) (human, bovine, porcine, rat) ... (VIP) receptor antagonist. This carboxy-terminal ... be twofold more potent than ... antagonists. Storage: ...
Protein 3D structure prediction, via threading. Easy to use....
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
Biology Products: